Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.7% in the last trading session to close at $22.36. The move was backed by solid volume with far more shares changing hands than in a normal ...
Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.8% in the last trading session to close at $21.17. The move was backed by solid volume with far more shares changing hands than in a normal ...
A newly released economic impact study by the Docking Institute of Public Affairs at Fort Hays State University confirms the ...
The usefulness of sentinel lymph node (SLN) biopsy was investigated among patients with melanoma and SLN metastases. Known to be effective for staging cutaneous melanoma, sentinel lymph node (SLN) ...
An integrated 31-GEP (i31-GEP) neural network algorithm incorporating clinicopathologic features with the continuous 31-GEP score was developed using a previously reported patient cohort (n = 1,398) ...
Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback